3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
2
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
218
Rectal Neoplasms
107
Colonic Neoplasms
91
Pancreatic Neoplasms
88
Stomach Neoplasms
75
Neoplasm Metastasis
61
Esophageal Neoplasms
40
Carcinoma, Hepatocellular
31
Lymphoma
24
Adenocarcinoma Of Esophagus
24
Neoplasms
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22
Adenocarcinoma
19
Leukemia
17
Cholangiocarcinoma
15
Biliary Tract Neoplasms
15
Burkitt Lymphoma
14
Gastrointestinal Neoplasms
12
Lymphoma, Non-Hodgkin
11
Osteosarcoma
9
Liver Neoplasms
9
Gallbladder Neoplasms
9
Esophageal Squamous Cell Carcinoma
9
Peritoneal Neoplasms
8
Leukemia, Myeloid, Acute
8
Myelodysplastic Syndromes
7
Lymphoma, Large B-Cell, Diffuse
7
Bile Duct Neoplasms
7
Unspecified Adult Solid Tumor, Protocol Specific
6
Multiple Myeloma
6
Interventions
Gemcitabine
5
Irinotecan
2
Albumin-Bound Paclitaxel
2
regorafenib
1
pembrolizumab
1
olaparib
1
ibrutinib
1
Tetrahydrouridine
1
Telemedicine
1
Taxes
1
Practice Guidelines as Topic
1
Paclitaxel
1
Oxaliplatin
1
Leucovorin
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Docetaxel
1
Decitabine
1
Counseling
1
Cisplatin
1
Capecitabine
1
BKT140
1
4-fluorobenzoyl-TN-14003
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Metastatic Pancreatic Adenocarcinoma
×
Leucovorin
×
Clear all
NCT01729481
2017-07-19
ML22774
Ludwig-Maximilians - University of Munich
Phase 2
Unknown
150 enrolled